Incidence of Non-Melanoma Skin Cancers in Salento (Southern Italy): A 15-Year Retrospective Analysis from the Cancer Registry of Lecce

Overview

Journal Epidemiologia (Basel)

Publisher MDPI

Specialty Public Health

Date 2024 Mar 27

PMID 38534803

Authors

Emiliano Sordi

Prisco Piscitelli

Carla Albanese

Anna Melcarne

Anna Tardio

Fabrizio Quarta

Enrico Greco

Alessandro Miani

Andrea Falco

Elisabetta De Matteis

Maurizio Congedo

Adele Civino

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Non-melanoma skin cancers (NMSCs) include basal cell carcinoma (BCC) and squamous-cell carcinoma (SCC), as well as a wide range of rare skin tumors. NMSCs is the most frequently diagnosed type of tumor among Caucasians. We aimed at estimating the incidence and mortality of NMSCs in the Salento area (Lecce province, Southern Italy), whose population is assumed to experience heavy and frequent sun exposure due to climatic/environmental factors, both for working and leisure activities.

Materials And Methods: We computed the incidence of NMSCs in the Province of Lecce by examining the comprehensive real-world data collected by the local cancer registry, which covers all the 830,000 inhabitants, over a period of fifteen years (from 2003 to 2017), with a focus on the latest 5 years (2013-2017) for the analysis of the different histologic morphologies of these tumors. The incidence of NMSCs has been described in terms of absolute frequencies, crude rates and age-adjusted direct standardized rates (DSR). Joinpoint analysis was used to examine temporal trends in the incidence of NMSCs and estimate annual percent changes (APCs).

Results: During the period of 2003-2017, the incidence of NMSCs reached a direct standardized rate (DSR) of 162.62 per 100,000 in men (mortality 1.57 per 100,000) and 89.36 per 100,000 in women (mortality 0.52 per 100,000), respectively. The incidence significantly increased among both men and women across the entire period. Basal cell carcinoma (BCC), with its different morphologies, represented about 67.6% of the NMSCs in men ( = 2139 out of a total of 3161 tumors observed between 2013 and 2017) and about 75.8% of the NMSCs in women ( = 1718 out of a total of 2264 tumors from 2013 to 2017), thus accounting for the vast majority of NMSCs. The results are consistent with the literature data carried out both at national and international level.

Conclusions: Proper monitoring of this phenomenon through timely reporting and recording of all new NMSC cases is necessary to develop new preventive strategies.

References

Losquadro W . Anatomy of the Skin and the Pathogenesis of Nonmelanoma Skin Cancer. Facial Plast Surg Clin North Am. 2017; 25(3):283-289. DOI: 10.1016/j.fsc.2017.03.001. View

Bernat Garcia J, Morales Suarez-Varela M, Vilata J, Marquina A, Pallardo L, Crespo J . Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region. Acta Derm Venereol. 2013; 93(4):422-7. DOI: 10.2340/00015555-1525. View

Flohil S, Seubring I, van Rossum M, Coebergh J, de Vries E, Nijsten T . Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study. J Invest Dermatol. 2012; 133(4):913-8. DOI: 10.1038/jid.2012.431. View

Ziegler A, Leffell D, Kunala S, Sharma H, Gailani M, Simon J . Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A. 1993; 90(9):4216-20. PMC: 46477. DOI: 10.1073/pnas.90.9.4216. View

Leiter U, Garbe C . Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. Adv Exp Med Biol. 2008; 624:89-103. DOI: 10.1007/978-0-387-77574-6_8. View

Griffin L, Ali F, Lear J . Non-melanoma skin cancer. Clin Med (Lond). 2016; 16(1):62-5. PMC: 4954336. DOI: 10.7861/clinmedicine.16-1-62. View

Barton V, Armeson K, Hampras S, Ferris L, Visvanathan K, Rollison D . Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review. Arch Dermatol Res. 2017; 309(4):243-251. PMC: 5396844. DOI: 10.1007/s00403-017-1724-5. View

Qureshi A, Wei-Passanese E, Li T, Han J . Host risk factors for the development of multiple non-melanoma skin cancers. J Eur Acad Dermatol Venereol. 2012; 27(5):565-70. PMC: 4196674. DOI: 10.1111/j.1468-3083.2012.04483.x. View

Leonardi-Bee J, Ellison T, Bath-Hextall F . Smoking and the risk of nonmelanoma skin cancer: systematic review and meta-analysis. Arch Dermatol. 2012; 148(8):939-46. DOI: 10.1001/archdermatol.2012.1374. View

10.

Marzuka A, Book S . Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015; 88(2):167-79. PMC: 4445438. View

11.

Lomas A, Leonardi-Bee J, Bath-Hextall F . A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012; 166(5):1069-80. DOI: 10.1111/j.1365-2133.2012.10830.x. View

12.

Hoashi T, Kanda N, Saeki H . Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma. Int J Mol Sci. 2022; 23(19). PMC: 9570397. DOI: 10.3390/ijms231911968. View

13.

Zaar O, Gillstedt M, Lindelof B, Wennberg-Larko A, Paoli J . Merkel cell carcinoma incidence is increasing in Sweden. J Eur Acad Dermatol Venereol. 2016; 30(10):1708-1713. DOI: 10.1111/jdv.13698. View

14.

Corneli P, Conforti C, Retrosi C, Vezzoni R, Di Meo N, Piccolo V . Pattern of response of unresectable and metastatic cutaneous squamous cell carcinoma to programmed death-1 inhibitors: A review of the literature. Dermatol Ther. 2020; 33(2):e13250. DOI: 10.1111/dth.13250. View

15.

Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D . Epidemiological trends in skin cancer. Dermatol Pract Concept. 2017; 7(2):1-6. PMC: 5424654. DOI: 10.5826/dpc.0702a01. View

16.

Madan V, Lear J, Szeimies R . Non-melanoma skin cancer. Lancet. 2010; 375(9715):673-85. DOI: 10.1016/S0140-6736(09)61196-X. View

17.

Cameron M, Lee E, Hibler B, Barker C, Mori S, Cordova M . Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2018; 80(2):303-317. DOI: 10.1016/j.jaad.2018.03.060. View

18.

Kim H, Fay M, Feuer E, Midthune D . Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3):335-51. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. View

19.

Lewis K, Weinstock M . Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol. 2004; 140(7):837-42. DOI: 10.1001/archderm.140.7.837. View

20.

Apalla Z, Nashan D, Weller R, Castellsague X . Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches. Dermatol Ther (Heidelb). 2017; 7(Suppl 1):5-19. PMC: 5289116. DOI: 10.1007/s13555-016-0165-y. View